The COVID-19 pandemic has had significant impacts on healthcare systems around the
world, including in Latin America. In Colombia, there have been over 23,000 confirmed …

Background. Several drugs which are easy to administer in outpatient settings have been
authorized and endorsed for high-risk COVID-19 patients with mild–moderate disease to …

Objective To determine the effectiveness of nirmatrelvir/ritonavir and molnupiravir among
vaccinated and unvaccinated non-hospitalized adults with COVID-19. Methods …

Molnupiravir, an urgently approved drug during the Coronavirus Disease 2019 (COVID-19)
pandemic, serves as the basis for our study, which relies on the Food and Drug …

This study aimed to explore the effectiveness and safety of azvudine, nirmatrelvir/ritonavir,
and molnupiravir in adult patients with mild-to-moderate COVID-19. This retrospective cohort …

Abstract Background and Aim This systematic review and meta‐analysis aimed to compare
the effectiveness and safety of molnupiravir and sotrovimab in the treatment of patients with …

Background This study aims to compare the effectiveness and safety of nirmatrelvir/ritonavir
(Paxlovid) and sotrovimab for coronavirus disease 2019 (COVID-19). Methods A search was …

Objective This study aimed to explore the efficacy and safety of small-molecule antivirals for
treating coronavirus disease 2019 (COVID-19). Methods Seven databases were searched …

Background The majority of available data on molnupiravir come from an unvaccinated
COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence …

Background In the context of increasing reports of co-infection with coronavirus disease
2019 (COVID-19), particularly with human herpes viruses (HHVs), it is important to consider …